Home > Financial Ratios > AAREY DRUGS & PHARMACEUTICALS

AAREY DRUGS & PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
COMMUNITY POLL
for AAREY DRUGS & PHARMACEUTICALS
Please provide your vote to see the results

AAREY DRUGS & PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 13.599.298.476.144.89

What is the latest EV/Core EBITDA ratio of AAREY DRUGS & PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of AAREY DRUGS & PHARMACEUTICALS is 13.59 based on Mar2024 Standalone results.
Year EV/Core EBITDA
Mar202413.59
Mar20239.29
Mar20228.47
Mar20216.14
Mar20204.89

How is EV/Core EBITDA of AAREY DRUGS & PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2024 13.59
46.29
Mar2023 9.29
9.68
Mar2022 8.47
37.95
Mar2021 6.14
25.56
Mar2020 4.89 -

Other Financial Ratios of AAREY DRUGS & PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of AAREY DRUGS & PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AAREY DRUGS & PHARMACEUTICALS ₹147.0 Cr -5.1% -1.8% 3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹400,125.0 Cr 0.1% -9.1% 13.3% Stock Analytics
DIVIS LABORATORIES ₹173,358.0 Cr -1.6% 6.5% 47% Stock Analytics
CIPLA ₹118,957.0 Cr 0.3% -4.6% -1.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹106,087.0 Cr -0.9% -4.5% 15.3% Stock Analytics
DR REDDYS LABORATORIES ₹104,197.0 Cr 0.4% 6.5% 4.1% Stock Analytics


AAREY DRUGS & PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AAREY DRUGS & PHARMACEUTICALS

-5.1%

-1.8%

3%

SENSEX

-1%

0.3%

7.4%


You may also like the below Video Courses